• SDSN - Greece
• Publications close
• RW close

Abstract. Mercury, Hg, is one of the most problematic metals from an environmental perspective. To assess the problems caused by Hg in the environment it is crucial to understand the processes of Hg biogeochemistry, but the exchange of Hg between the atmosphere and vegetation is not sufficiently well characterised. We explored the mercury concentration, [Hg], in foliage from a diverse set of plant types, locations and sampling periods to study whether there is a continuous accumulation of Hg in leaves/needles over time. Measurements of [Hg] were made in deciduous and conifer trees in Gothenburg, Sweden (Botanical Garden and city area) as well as of evergreen trees in Rwanda. In addition, data for wheat from an ozone experiment conducted at Östad, Sweden, were included. Conifer data were quantitatively compared with literature data. In every case where older foliage was directly compared with younger, [Hg] was higher in older tissue. Covering the range of current year up to four-year old needles, there was no sign of Hg saturation in conifer needles with age. Thus, over time scales of approximately one month to several years, the Hg uptake in foliage from the atmosphere always dominated over Hg evasion. Rwandan broadleaved trees had generally older leaves due to lack of seasonal abscission and higher [Hg] than Swedish broadleaved trees. The significance of atmospheric Hg uptake in plants was shown in a wheat experiment where charcoal filtrated air lead to significantly lower leaf [Hg]. To search for general patterns, the accumulation rates of Hg in the diverse set of tree species in the Gothenburg area were related to the specific leaf area (SLA). Leaf area based [Hg] was strongly negatively and non-linearly correlated with SLA, while mass-based [Hg] had a somewhat weaker positive relationship with SLA (both relationships with p < 0.001). An elaborated understanding of the relationship behind [Hg] and SLA would support large-scale modelling of Hg uptake by vegetation and Hg circulation in general.

ABSTRACT Background The Mediterranean diet (MD) is widely recommended for the prevention of chronic disease, but evidence for a beneficial effect on bone health is lacking. Objective The aim of this study was to examine the effect of a Mediterranean-like dietary pattern [NU-AGE (New Dietary Strategies Addressing the Specific Needs of the Elderly Population for Healthy Aging in Europe)] on indexes of inflammation with a number of secondary endpoints, including bone mineral density (BMD) and biomarkers of bone and collagen degradation in a 1-y multicenter randomized controlled trial (RCT; NU-AGE) in elderly Europeans. Design An RCT was undertaken across 5 European centers. Subjects in the intervention group consumed the NU-AGE diet for 1 y by receiving individually tailored dietary advice, coupled with supplies of foods including whole-grain pasta, olive oil, and a vitamin D3 supplement (10 µg/d). Participants in the control group were provided with leaflets on healthy eating available in their country. Results A total of 1294 participants (mean ± SD age: 70.9 ±4.0 y; 44% male) were recruited to the study and 1142 completed the 1-y trial. The Mediterranean-like dietary pattern had no effect on BMD (site-specific or whole-body); the inclusion of compliance to the intervention in the statistical model did not change the findings. There was also no effect of the intervention on the urinary biomarkers free pyridinoline or free deoxypyridinoline. Serum 25-hydroxyvitamin D significantly increased and parathyroid hormone decreased (P < 0.001) in the MD compared with the control group. Subgroup analysis of individuals with osteoporosis at baseline (site-specific BMD T-score ≤ −2.5 SDs) showed that the MD attenuated the expected decline in femoral neck BMD (n = 24 and 30 in MD and control groups, respectively; P = 0.04) but had no effect on lumbar spine or whole-body BMD. Conclusions A 1-y intervention of the Mediterranean-like diet together with vitamin D3 supplements (10 µg/d) had no effect on BMD in the normal age-related range, but it significantly reduced the rate of loss of bone at the femoral neck in individuals with osteoporosis. The NU-AGE trial is registered at clinicaltrials.gov as NCT01754012.